Vitamin E Does Not Cause Increased MCV or MCHC
Vitamin E supplementation does not directly cause increases in mean corpuscular volume (MCV) or mean corpuscular hemoglobin concentration (MCHC). In fact, the available evidence suggests vitamin E may have the opposite effect on MCV in certain contexts, while MCHC changes are not a recognized consequence of vitamin E therapy.
Evidence from Clinical Studies
The most relevant research directly addressing this question comes from a 2006 study examining vitamin E supplementation in iron deficiency anemia treatment. In patients receiving both iron and vitamin E (compared to iron alone), MCV was actually found to be higher at the end of therapy, suggesting vitamin E may accelerate recovery from microcytosis rather than causing macrocytosis 1. This reflects improved red blood cell maturation, not a pathological increase in cell size.
A 2006 study in hemoglobin-E carriers treated with 200 IU vitamin E daily for 3 months found that MCV did not change significantly with vitamin E supplementation 2. This demonstrates that vitamin E alone does not alter red blood cell size parameters in healthy carriers.
Important Safety Consideration: Iron Deficiency Risk
While vitamin E doesn't increase MCV or MCHC, there is a critical safety concern you should monitor. A 2025 prospective study found that 55% of patients with metabolic dysfunction-associated steatotic liver disease developed iron deficiency after a median of 11 weeks of vitamin E treatment (200-800 IU/day), with 30% developing anemia 3. This occurred through occult gastrointestinal bleeding, likely reflecting vitamin E's effect on platelet function.
Key Clinical Implications:
- Iron deficiency from vitamin E treatment causes decreased MCV (microcytosis), not increased MCV 3
- Ferritin decreased significantly (84.5 to 47.8 μg/L, p<0.001)
- MCV actually decreased (86.2 to 84.3 fL, p=0.003)
- Red cell distribution width (RDW) increased (13.4 to 14.4%, p=0.003)
- Risk was highest in diabetics (100% vs 47% in non-diabetics, p=0.007)
What Actually Causes Increased MCV
According to established guidelines, macrocytosis (increased MCV) indicates vitamin B12 or folate deficiency, and also arises from thiopurine treatment, other medications, alcohol abuse, hypothyroidism, or reticulocytosis 444. Vitamin E is not listed among these causes in any major guideline.
Monitoring Recommendations
If prescribing vitamin E supplementation (particularly doses >200 IU/day):
- Monitor CBC with ferritin at baseline and within the first 3 months of treatment
- Watch for decreasing MCV and ferritin (indicating iron deficiency)
- Be especially vigilant in diabetic patients
- Assess for gastrointestinal bleeding sources if iron deficiency develops
- Iron deficiency can be managed appropriately even with continued vitamin E treatment 3
The ESPEN guidelines confirm that vitamin E supplementation up to 3200 IU per day causes no consistent adverse effects, though bleeding risk exists, particularly in those on anticoagulants or with vitamin K deficiency 55.